Lactic acid bacteria capable of producing glutathione and redox in vivo / Trademark acquired for "Shiratama Lactic Acid Bacteria"
ME-3 has a mechanism for synthesizing and redox cycling glutathione, and various physiological activities, including antioxidant properties, are expected. It is intended for supplements aimed at beauty and metabolic health. It was named "Shiratama Lactic Acid Bacteria" to evoke the image of beautiful, white, and chewy shiratama, making it easy to associate with beauty. ("Shiratama Lactic Acid Bacteria" is a registered trademark of Seti Co., Ltd.) ■Limosilactobacillus fermentum ME-3 Limosilactobacillus fermentum ME-3 (Former scientific name: Lactobacillus fermentum) <Features> ● Live bacteria ● Capable of producing glutathione in vivo ● Human-derived, discovered in 1995, isolated from a healthy 1-year-old child ● Clinical data available (antioxidant, lipid metabolism) ● Safety (listed in EFSA QPS)
Inquire About This Product
basic information
● Live bacteria ● Capable of producing glutathione in vivo ● Human-derived, discovered in 1995. Isolated from a healthy 1-year-old child ● Acid-resistant ● Clinical data available ● Safety (listed in EFSA QPS)
Price range
Delivery Time
Applications/Examples of results
Various supplements, various food applications, etc.
Company information
Seti is a health science company primarily engaged in the handling of functional ingredients, in vitro diagnostic pharmaceuticals, and medical devices. In the health science division, we introduce unique functional food ingredients and general food ingredients collected from around the world.
